| Acute Myeloid Leukemia with del(5q) studied in …STUDIED_INderived103 of 103show fewer |
|---|
| → studied in | NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02094794Phase 2 · active not recruiting Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869114Phase 2 · completed Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822015early Phase 1 · completed Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540995Phase 1/Phase 2 · terminated Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122081Phase 1 · completed Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299518Phase 1 · completed Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119366Phase 2 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01555268Phase 1 · completed Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01550185Phase 1 · terminated Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01876953Phase 1/Phase 2 · terminated Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02105116NA · terminated AML Therapy With Irradiated Allogeneic Cells · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02144675Phase 2 · completed Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00860574Phase 2 · completed Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01246622Phase 1 · completed Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869777NA · completed Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01235572Phase 2 · completed Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839240Phase 1 · completed Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02316964Phase 1 · completed Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040846Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045435Phase 2 · completed Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01707004Phase 2 · completed Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008177Phase 1 · completed Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00856388NA · completed Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529827Phase 2 · completed Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005799NA · completed Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01519596NA · completed Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839916Phase 2 · completed Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159067Phase 2 · terminated Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02030405Phase 2 · terminated Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175785Phase 2 · completed Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849276Phase 1 · terminated Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02019069Phase 2 · completed CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904643Phase 1 · terminated Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01846624Phase 2 · terminated Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253447Phase 2 · completed AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795002Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872819NA · completed Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01768897Phase 1 · completed CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548911Phase 2 · withdrawn Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666588Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835288Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357032Phase 2 · completed PXD101 in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01801046Phase 1 · terminated Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01798901Phase 1 · completed AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01842139Phase 1 · completed Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869803approved for marketing Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01564277Phase 2 · terminated Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445744NA · completed Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049801Phase 1 · terminated MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831232NA · completed Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01101880Phase 2 · completed Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005940Phase 2 · completed Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01141725Phase 1/Phase 2 · completed Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349972Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00839982Phase 1/Phase 2 · completed Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01342887Phase 1/Phase 2 · terminated Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003875Phase 2 · completed Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673153Phase 2 · terminated Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01083706Phase 2 · completed Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049504Phase 2 · completed Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01820624Phase 1 · completed Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465386Phase 2 · terminated Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093743Phase 1 · completed Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052598Phase 1/Phase 2 · terminated Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567059Phase 2 · completed Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174888Phase 1 · completed Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492401Phase 2 · completed Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029417Phase 2 · terminated Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01056614Phase 2 · completed Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062075Phase 2 · completed Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01127009Phase 1 · completed Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01521936Phase 2 · terminated Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343798Phase 1 · completed A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00322101Phase 3 · completed Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602771Phase 2 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01233921NA · completed Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079378Phase 1 · completed Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159301Phase 1 · terminated Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003190Phase 3 · completed Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006363Phase 3 · completed Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027872Phase 2 · completed Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101296Phase 1 · completed Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093418Phase 2 · completed S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012376Phase 1 · completed Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045396Phase 2 · completed A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS) · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131989Phase 1 · completed Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357708Phase 1 · completed Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01558778NA · withdrawn Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177371Phase 2 · completed High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 103 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with del(5q) | 1 | Observed | clinicaltrials | graph → |